Safecode Drug (SAFC) Recap of Headlines
FDA Approved Painless Injection Device
PR Newswire - Wed Apr 17, 7:30AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of technologies that reduces errors and eliminates pain during the administration of prescription medications, announced today that the company intends to hire a Project Manager to oversee and implement a marketing strategy to commercialize its newly acquired painless injection device.
SafeCode Drug Technologies Initiating Activities to Commercialize its Recent Newly Acquired Technology of the Pain-Free Injection
PR Newswire - Thu Mar 21, 8:00AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of voice activated drug safety application announced today that the company is actively initiating a business development plan to commercialize its newly acquired technology.
SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
M2 - Tue Mar 12, 9:19AM CDT
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, announced today that the company has acquired breakthrough Quickool technology enabling individuals to self-administer pain free injections.
Medisafe 1 Technologies One-Time Special Dividend Announced
PR Newswire - Thu Feb 21, 7:40AM CST
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
Safecode Drug Technologies Receives Investment From Biomedix Ltd
M2 - Mon Jan 07, 8:35AM CST
JERUSALEM, January 7, 2013 -- Israel's publicly-traded (TASE) BioMedix Agrees to Purchase SAFC at 0.15 cents Per Share
SafeCode Drug Technologies Corporation Announce Share Buy Back Program
PR Newswire - Wed Jan 02, 7:45AM CST
SafeCode Drug Technologies Corp. (OTCBB: SAFC), a developer of a voice recognition drug administration safety application announced today that the share Buyback Program which was authorized by the Board Of Directors will commence during the month of January 2013 and is expected to last approximately 1-3 months. The shares will be returned to the Treasury of the Company to be used for further issuances for future acquisitions of companies or technology applications in the medical industry. Funding for the acquisition of the shares will be subject to financing from third parties.
AI
